-
1
-
-
0029895009
-
TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex
-
Bajzar, L., Morser, J., Nesheim, M., 1996. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J. Biol. Chem. 271, 16603-16608.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 16603-16608
-
-
Bajzar, L.1
Morser, J.2
Nesheim, M.3
-
2
-
-
0035826096
-
Efficacy and safety of recombinant human activated protein C for severe sepsis
-
Bernard, G.R., Vincent, J.L., Laterre, P.F., LaRosa, S.P., et al., 2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344, 699-709.
-
(2001)
N. Engl. J. Med.
, vol.344
, pp. 699-709
-
-
Bernard, G.R.1
Vincent, J.L.2
Laterre, P.F.3
LaRosa, S.P.4
-
3
-
-
10544253848
-
Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots fromhemophilic plasma
-
Broze, G., Higuchi, D.A., 1996. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots fromhemophilic plasma. Blood 88, 3815-3823.
-
(1996)
Blood
, vol.88
, pp. 3815-3823
-
-
Broze, G.1
Higuchi, D.A.2
-
4
-
-
0036191244
-
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N
-
Campbell, W.D., Lazoura, E., Okada, N., Okada, H., 2002. Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol. Immunol. 46, 131-134.
-
(2002)
Microbiol. Immunol.
, vol.46
, pp. 131-134
-
-
Campbell, W.D.1
Lazoura, E.2
Okada, N.3
Okada, H.4
-
5
-
-
2942703945
-
Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery
-
Carter, W.J., Myles, T., Gibbs, C.S., Leung, L.L., Huntington, J.A., 2004. Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery. J. Biol. Chem. 279, 26387-26394.
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 26387-26394
-
-
Carter, W.J.1
Myles, T.2
Gibbs, C.S.3
Leung, L.L.4
Huntington, J.A.5
-
6
-
-
43449093705
-
Evidence for non-traditional activation of complement factor C3 during murine liver regeneration
-
Clark, A., Weymann, A., Hartman, E., Turmelle, Y., Carroll, M., Thurman, J.M., Holers, V.M., Hourcade, D.E., Rudnick, D.A., 2008. Evidence for non-traditional activation of complement factor C3 during murine liver regeneration. Mol. Immunol. 45, 3125-3132.
-
(2008)
Mol. Immunol.
, vol.45
, pp. 3125-3132
-
-
Clark, A.1
Weymann, A.2
Hartman, E.3
Turmelle, Y.4
Carroll, M.5
Thurman, J.M.6
Holers, V.M.7
Hourcade, D.E.8
Rudnick, D.A.9
-
7
-
-
28344436780
-
Protease-activated receptors in hemostasis, thrombosis and vascular biology
-
Coughlin, S.R., 2005. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J. Thromb. Haemost. 3, 1800-1814.
-
(2005)
J. Thromb. Haemost.
, vol.3
, pp. 1800-1814
-
-
Coughlin, S.R.1
-
8
-
-
0141819138
-
The protein C pathway
-
Esmon, C.T., 2003. The protein C pathway. Chest 124, 26S-32S.
-
(2003)
Chest
, vol.124
-
-
Esmon, C.T.1
-
9
-
-
33644801469
-
The interactions between inflammation and coagulation
-
Esmon, C.T., 2005. The interactions between inflammation and coagulation. Br. J. Haematol. 131, 417-430.
-
(2005)
Br. J. Haematol.
, vol.131
, pp. 417-430
-
-
Esmon, C.T.1
-
10
-
-
0028811156
-
Conversion of thrombin into an anticoagulant by protein engineering
-
Gibbs, C.S., Coutre, S.E., Tsiang, M., Li, W.X., Jain, A.K., Dunn, K.E., Law, V.S., Mao, C.T., Matsumura, S.Y., Mejsa, S.J., Paborsky, L.R., Leung, L.L.K., 1995. Conversion of thrombin into an anticoagulant by protein engineering. Nature 378, 413-416.
-
(1995)
Nature
, vol.378
, pp. 413-416
-
-
Gibbs, C.S.1
Coutre, S.E.2
Tsiang, M.3
Li, W.X.4
Jain, A.K.5
Dunn, K.E.6
Law, V.S.7
Mao, C.T.8
Matsumura, S.Y.9
Mejsa, S.J.10
Paborsky, L.R.11
Leung, L.L.K.12
-
11
-
-
33744987414
-
Generation of C5a in the absence of C3: a new complement activation pathway
-
Huber-Lang, M., Sarma, J.V., Zetoune, F.S., Rittirsch, D., Neff, T.A., McGuire, S.R., Lambris, J.D., Warner, R.L., Flierl, M.A., Hoesel, L.M., Gebhard, F., Younger, J.G., Drouin, S.M., Wetsel, R.A., Ward, P.A., 2006. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12, 682-687.
-
(2006)
Nat. Med.
, vol.12
, pp. 682-687
-
-
Huber-Lang, M.1
Sarma, J.V.2
Zetoune, F.S.3
Rittirsch, D.4
Neff, T.A.5
McGuire, S.R.6
Lambris, J.D.7
Warner, R.L.8
Flierl, M.A.9
Hoesel, L.M.10
Gebhard, F.11
Younger, J.G.12
Drouin, S.M.13
Wetsel, R.A.14
Ward, P.A.15
-
12
-
-
0030878076
-
Modulation of thrombin's procoagulant and anticoagulant properties
-
Leung, L.L.K., Gibbs, C.S., 1997. Modulation of thrombin's procoagulant and anticoagulant properties. Thromb. Haemost. 78, 577-580.
-
(1997)
Thromb. Haemost.
, vol.78
, pp. 577-580
-
-
Leung, L.L.K.1
Gibbs, C.S.2
-
13
-
-
0345803939
-
Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation
-
Myles, T., Nishimura, T., Yun, T.H., Nagashima, M., Morser, J., Patterson, A.J., Pearl, R.G., Leung, L.L.K., 2003. Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation. J. Biol. Chem. 278, 51059-51067.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 51059-51067
-
-
Myles, T.1
Nishimura, T.2
Yun, T.H.3
Nagashima, M.4
Morser, J.5
Patterson, A.J.6
Pearl, R.G.7
Leung, L.L.K.8
-
14
-
-
49649095966
-
Thrombin hydrolysis of human osteopontin is dependent on thrombin anion-binding exosites
-
Myles, T., Leung, L.L.K., 2008. Thrombin hydrolysis of human osteopontin is dependent on thrombin anion-binding exosites. J. Biol. Chem. 283, 17789-17796.
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 17789-17796
-
-
Myles, T.1
Leung, L.L.K.2
-
15
-
-
33847357422
-
Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo
-
Nishimura, T., Myles, T., Piloponsky, P., Kao, P., Berry, G.J., Leung, L.L.K., 2007. Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo. Blood 109, 1992-1997.
-
(2007)
Blood
, vol.109
, pp. 1992-1997
-
-
Nishimura, T.1
Myles, T.2
Piloponsky, P.3
Kao, P.4
Berry, G.J.5
Leung, L.L.K.6
-
16
-
-
0028815556
-
Plasma carboxypeptidases as regulators of the plasminogen system
-
Redlitz, A., Tan, A.K., Eaton, D.L., Plow, E.F., 1995. Plasma carboxypeptidases as regulators of the plasminogen system. J. Clin. Invest. 96, 2534-2538.
-
(1995)
J. Clin. Invest.
, vol.96
, pp. 2534-2538
-
-
Redlitz, A.1
Tan, A.K.2
Eaton, D.L.3
Plow, E.F.4
-
17
-
-
0028348825
-
Pro-carboxypeptidase R cleaves bradykinin following activation
-
Shinohara, T., Sakurada, C., Suzuki, T., Takeuchi, O., Campbell, W., Ikeda, S., Okada, N., Okasda, H., 1994. Pro-carboxypeptidase R cleaves bradykinin following activation. Int. Arch. Allergy Immunol. 103, 400-404.
-
(1994)
Int. Arch. Allergy Immunol.
, vol.103
, pp. 400-404
-
-
Shinohara, T.1
Sakurada, C.2
Suzuki, T.3
Takeuchi, O.4
Campbell, W.5
Ikeda, S.6
Okada, N.7
Okasda, H.8
-
18
-
-
64749106767
-
Thrombin-activatable carboxypeptidase B prevents anti-collagen antibody induced arthritis
-
Song, J., Nishimura, T., Garcia, M., Myles, T., Ho, P., Du, X.Y., Sharif, S., Leung, L., Robinson, W., 2007. Thrombin-activatable carboxypeptidase B prevents anti-collagen antibody induced arthritis. Clin. Immunol. 123 (Suppl.), S98.
-
(2007)
Clin. Immunol.
, vol.123
, Issue.SUPPL.
-
-
Song, J.1
Nishimura, T.2
Garcia, M.3
Myles, T.4
Ho, P.5
Du, X.Y.6
Sharif, S.7
Leung, L.8
Robinson, W.9
-
19
-
-
12644264319
-
Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo
-
Tsiang, M., Paborsky, L.R., Li, W.X., Jain, A.K., Mao, C.T., Dunn, K.E., Lee, D.W., Matsumura, S.Y., Matteucci, M.D., Coutre, S.E., Leung, L.L.K., Gibbs, C.S., 1996. Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo. Biochemistry 35, 16449-16457.
-
(1996)
Biochemistry
, vol.35
, pp. 16449-16457
-
-
Tsiang, M.1
Paborsky, L.R.2
Li, W.X.3
Jain, A.K.4
Mao, C.T.5
Dunn, K.E.6
Lee, D.W.7
Matsumura, S.Y.8
Matteucci, M.D.9
Coutre, S.E.10
Leung, L.L.K.11
Gibbs, C.S.12
|